NCT03911401View on ClinicalTrials.gov

Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

December 13, 2019

Study Completion Date

December 13, 2019

Conditions
Atopic Dermatitis
Interventions
DRUG

0.3% OPA-15406

Twice daily

DRUG

1% OPA-15406

Twice daily

DRUG

Placebos

Twice daily

Trial Locations (1)

Unknown

Kato Dermatology Clinic, Sapporo

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY